Research Article
Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations
Table 1
Average size, PDI, zeta potential, and encapsulation efficiency of single and dual drug loaded NPs.
| Sample | Components | Size (nm) | Polydispersity index (PDI) | Zeta potential (mV) |
| 1.1 | PLGA-CS-LMV | 233 | 0.084 | +25 | 1.2 | PLGA-CS-LMV | 231 | 0.072 | +19 | 1.3 | PLGA-CS-LMV | 240 | 0.127 | +28 | 1.4 | PLGA-CS-LMV | 244 | 0.148 | +25 | Mean | | 237 | 0.108 | +24 | Std. Dev. | | 6 | 0.04 | 3.9 | Average EE% | | 7.5% | | |
| 2.1 | PLGA-CS-NVP | 317 | 0.314 | +18 | 2.2 | PLGA-CS-NVP | 250 | 0.245 | +22 | 2.3 | PLGA-CS-NVP | 293 | 0.272 | +20 | 2.4 | PLGA-CS-NVP | 273 | 0.206 | +22 | Mean | | 283 | 0.259 | +20.4 | Std. Dev. | | 29 | 0.05 | 2.0 | Average EE% | | 7.5% | | |
| 3.1 | PLGA-CS-NVP-LMV | 246 | 0.176 | +23 | 3.2 | PLGA-CS-NVP-LMV | 242 | 0.131 | +25 | 3.3 | PLGA-CS-NVP-LMV | 261 | 0.151 | +15 | 3.4 | PLGA-CS-NVP-LMV | 220 | 0.122 | +21 | Mean | | 242 | 0.145 | +21 | Std. Dev. | | 17 | 0.02 | 4.2 | Average EE% | | 13% | | |
| 4.1 | PLGA-CS | 227 | 0.010 | +21 | 4.2 | PLGA-CS | 242 | 0.118 | +18 | Mean | | 235 | 0.064 | +20 | Std. Dev. | | 11 | 0.08 | 1.8 |
| 5.1 | PLGA-LMV | 278 | 0.125 | −21 |
| 6.1 | PLGA-NVP | 306 | 0.305 | −9 |
|
|